BAY o 1248,
BAY-o 1248,
BAY-o-1248,
emiglitate,
N-(beta-(4-ethoxycarbonyl)phenoxy)ethyl-1-desoxy-nojirimycin,
N-(beta-(4-ethoxycarbonyl)phenoxy)ethyl-1-desoxynojirimycin,
Emiglitate,
80879-63-6,
Emiglitatum [Latin],
Emiglitato [Spanish],
UNII-PF8AB2IBUM,
Bay-o-1248,
BAY o 1248,
PF8AB2IBUM,
EINECS 279-613-2,
BAY-o 1248,
MKC-542,
NCGC00183836-01,
Emiglitato,
Emiglitatum,
1,5-Dideoxy-1,5-((2-(4-(ethoxycarbonyl)phenoxy)ethyl)imino)-D-glucitol,
Ethyl p-(2-((2R,3R,4R,5S)-3,4,5-trihydroxy-2-(hydroxymethyl)piperidino)ethoxy)benzoate,
Benzoic acid,4-[2-[(2R,3R,4R,5S)-3,4,5-trihydroxy-2-(hydroxymethyl)-1-piperidinyl]ethoxy]-,ethyl ester,
Emiglitate [BAN:INN],
Emiglitate [INN:BAN],
Emiglitate (JAN/INN),
AC1L2H8D,
AC1Q64TL,
DSSTox_CID_28725,
DSSTox_RID_82994,
DSSTox_GSID_48799,
SCHEMBL26909,
CHEMBL2106304,
DTXSID2048799,
CTK5E8287,
ZINC4215778,
Tox21_113276,
CS-6655,
HY-16194,
CAS-80879-63-6,
LS-177593,
D09779,
N-(beta-(4-ethoxycarbonyl)phenoxy)ethyl-1-desoxynojirimycin,
C17H25NO7,
CID72004,
AR-1I9160,
C17-H25-N-O7,
ethyl 4-[2-[(2R,3R,4R,5S)-3,4,5-trihydroxy-2-(hydroxymethyl),
ethyl 4-{2-[(2r,3r,4r,5s)-3,4,5-trihydroxy-2-(hydroxymethyl)piperidin-1-yl]ethoxy}benzoate,
1,5-dideoxy-1,5-[[2-[4-(ethoxycarbonyl)phenoxy]ethyl]imino]-D-glucitol,
853-66-7,
ethyl 4-[2-[(2R,3R,4R,5S)-3,4,5-trihydroxy-2-(hydroxymethyl)piperidin-1-yl]ethoxy]benzoate,